Tuberculosis (TB) Diagnostics Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Tuberculosis (TB) Diagnostics market size was valued at USD 2706.1 million in 2022 and is forecast to a readjusted size of USD 3635.2 million by 2029 with a CAGR of 4.3% during review period.

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%. APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent. In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.

This report is a detailed and comprehensive analysis for global Tuberculosis (TB) Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Tuberculosis (TB) Diagnostics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Tuberculosis (TB) Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Tuberculosis (TB) Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Tuberculosis (TB) Diagnostics market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tuberculosis (TB) Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Tuberculosis (TB) Diagnostics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Danaher
   Roche
   Thermo Fisher Scientific
   BD
   Abbott
   Hologic
   Qiagen
   BioMerieux
   Hain Lifescience
   Oxford Immunotec

   Culture-Based Diagnostics
   Sputum Smear Microscopy
   Rapid Molecular Diagnostics
   Others

   Diagnostic Laboratories
   Hospitals

   North America (United States, Canada, and Mexico)
   Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
   South America (Brazil, Argentina and Rest of South America)
   Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
 

What are the strengths of the TB diagnostics market in 2025?

The TB diagnostics market in 2025 benefits from technological advancements such as rapid diagnostic tests, PCR-based assays, and AI-powered diagnostic tools. These innovations lead to faster, more accurate results, helping in timely treatment and reducing transmission. Increased awareness and government funding also contribute to growth.

What weaknesses still exist in the TB diagnostics market?

Despite progress, challenges remain, including high costs for advanced diagnostic technologies, lack of infrastructure in low-income regions, and disparities in access to quality diagnostic tools. There are also issues with the availability of trained personnel in some areas, which hinders the effectiveness of new diagnostics.

What are the opportunities for the TB diagnostics market in 2025?

There are significant opportunities in expanding point-of-care testing, especially in remote areas. The growing focus on personalized medicine, coupled with innovations in mobile health technology, opens up new possibilities. Additionally, increased partnerships between public and private sectors could drive affordable diagnostic solutions for TB.

What threats could affect the TB diagnostics market in 2025?

Threats include the potential for emerging drug-resistant strains of TB, which could complicate diagnostics and treatment protocols. Economic instability in certain regions may limit healthcare funding, hindering progress. The ongoing challenge of global health inequity could also lead to uneven access to cutting-edge diagnostic tools.

What are the political factors influencing the TB diagnostics market in 2025?

Government policies and funding initiatives will continue to shape the TB diagnostics landscape. Strong political support for TB eradication programs can lead to better access to diagnostics in underserved regions. However, political instability in certain regions could hinder healthcare delivery and access to essential diagnostic tools.

How do economic factors impact the TB diagnostics market?

Economic factors such as healthcare budgets, affordability, and global economic growth play a significant role in the adoption of advanced TB diagnostics. In low-income countries, cost-effective diagnostic solutions are critical. Economic downturns could limit public health spending, slowing the adoption of newer technologies in poorer regions.

What social factors are affecting the TB diagnostics market?

Social factors like increasing health awareness, education about TB prevention, and public health initiatives play a key role in the demand for TB diagnostics. However, stigma associated with TB in some regions can hinder people from seeking timely diagnosis, affecting the overall market.

What technological factors are driving change in the TB diagnostics market?

Technological advancements in molecular diagnostics, artificial intelligence, and rapid testing have significantly enhanced the speed and accuracy of TB diagnostics. Innovations like mobile-based diagnostic tools are particularly promising for remote and underserved areas, improving access and patient outcomes.

What environmental factors could influence the TB diagnostics market?

Environmental factors, including the spread of multi-drug-resistant (MDR) TB due to poor living conditions and environmental hygiene, can impact the demand for advanced diagnostic tools. Climate change and migration patterns may also contribute to shifting disease prevalence, influencing where diagnostic tools are needed most.

What legal factors should be considered in the TB diagnostics market?

Regulatory frameworks and approval processes for diagnostic devices, particularly in emerging markets, will affect the speed at which new technologies are adopted. Intellectual property rights and patent laws also play a role in driving innovation while maintaining a balance with affordability and access to diagnostics.

Who are the suppliers in the TB diagnostics market in 2025?

Suppliers in the TB diagnostics market include manufacturers of diagnostic technologies like PCR machines, rapid diagnostic test kits, reagents, and AI-powered diagnostic software. Key players also include suppliers of consumables and healthcare infrastructure providers.

Who are the inputs for the TB diagnostics market?

Inputs include raw materials for diagnostic kits, reagents, technological innovations in diagnostics, data from clinical trials, research collaborations, and trained healthcare professionals. The availability of these inputs influences the development and deployment of new diagnostic tools.

What are the processes involved in the TB diagnostics market?

The main processes include the development and manufacturing of diagnostic tests, regulatory approval, distribution to healthcare facilities, and the actual use of these tests by healthcare providers. The process also involves training healthcare workers, ongoing maintenance, and quality control of diagnostic devices.

Who are the customers in the TB diagnostics market?

Customers are healthcare providers, including hospitals, clinics, laboratories, and public health organizations. These customers demand effective and affordable diagnostic solutions to manage and treat TB, particularly in high-risk or underserved regions.

What are the outputs of the TB diagnostics market?

The outputs include diagnostic test results, improved TB detection rates, reduced time to diagnosis, and better patient outcomes through timely treatment. In addition, market outputs also include increased access to diagnostics in low-resource settings and contributions to global TB eradication efforts.

What is the threat of new entrants in the TB diagnostics market in 2025?

The threat of new entrants is moderate. While there is a growing demand for innovative TB diagnostics, the high costs of research and development, regulatory hurdles, and the need for specialized expertise make it difficult for new companies to break into the market. Established players with strong intellectual property and global distribution networks hold a significant advantage.

What is the bargaining power of suppliers in the TB diagnostics market?

The bargaining power of suppliers is moderate to high. Suppliers of critical raw materials, reagents, and specialized diagnostic technology have significant influence over pricing and availability. However, the increasing number of suppliers and advancements in diagnostic technology may give companies more options, reducing the power of any single supplier.

What is the bargaining power of buyers in the TB diagnostics market?

The bargaining power of buyers is moderate. Governments, healthcare providers, and international health organizations are significant buyers of TB diagnostics, and they often demand high-quality, cost-effective solutions. However, because TB diagnostics are specialized, the number of available options is limited, giving suppliers some leverage over pricing.

What is the threat of substitutes in the TB diagnostics market?

The threat of substitutes is relatively low. While there are alternative diagnostic methods, such as clinical assessments and imaging techniques, these are not as reliable or efficient as molecular-based and rapid diagnostic tests. Advances in technology, such as AI and mobile health, may provide complementary tools, but they are unlikely to fully replace traditional diagnostic methods.

What is the intensity of competitive rivalry in the TB diagnostics market?

The intensity of competitive rivalry is high. There are several established players in the market, and competition is driven by innovation, regulatory approvals, and cost-effectiveness. Companies are continuously developing new technologies to improve diagnostic speed and accuracy, leading to frequent product launches and ongoing competition for market share.

What are the key raw materials needed for TB diagnostics in 2025?

The key raw materials include specialized reagents, chemicals for PCR and other molecular tests, lab consumables, and diagnostic equipment components like sensors, chips, and devices for rapid testing. High-quality materials are critical to ensure accurate and reliable test results.

Who are the primary suppliers involved in TB diagnostics development?

Primary suppliers include manufacturers of diagnostic technologies, pharmaceutical companies providing reagents, and producers of raw materials like plastics, glass, and metals used in lab equipment. Additionally, tech companies supplying AI and data analytics solutions play an important role in advancing diagnostic capabilities.

What are the main challenges faced by suppliers in the TB diagnostics market?

Suppliers face challenges such as rising raw material costs, stringent regulatory requirements, and the need for continuous innovation to meet evolving diagnostic needs. Supply chain disruptions, particularly in low-income regions, can also affect the timely availability of diagnostic tools.

How do technological advancements impact the upstream segment of the TB diagnostics market?

Technological advancements significantly influence the upstream segment by improving the efficiency of diagnostics development. Innovations in automation, AI, and molecular biology enhance the precision and speed of diagnostic tests. This leads to a growing demand for new, high-performance materials and technology components from suppliers.

What is the role of research and development in the upstream TB diagnostics market?

Research and development (R&D) play a crucial role in driving innovation in TB diagnostics. Suppliers must invest in R&D to develop new reagents, test platforms, and detection technologies. Ongoing R&D efforts ensure that diagnostic tools stay relevant to emerging TB strains, such as multi-drug-resistant TB, and improve testing accuracy.

What is the role of distribution channels in the TB diagnostics market in 2025?

Distribution channels are vital in ensuring that TB diagnostic tools reach healthcare facilities worldwide, especially in remote and underserved regions. The market relies on distributors, wholesalers, and direct supply chains to get diagnostic products into hospitals, clinics, and public health centers. Efficient logistics and partnerships with global health organizations help overcome geographical barriers.

What are the main processes in the midstream segment of the TB diagnostics market?

The midstream processes involve the manufacturing, packaging, and distribution of diagnostic products. This includes ensuring that diagnostic kits and devices meet regulatory standards, handling quality control, and managing the storage and transportation of products. Additionally, training healthcare workers and providing technical support are important processes to ensure accurate usage of diagnostic tools.

What are the key challenges in the midstream segment of the TB diagnostics market?

Key challenges include managing the complexity of global supply chains, especially in areas with limited infrastructure. Ensuring the cold chain for sensitive diagnostic products, overcoming logistical bottlenecks in remote areas, and complying with local regulations can also complicate midstream operations. Additionally, balancing cost-efficiency with maintaining product quality is a constant challenge.

How do partnerships impact the midstream segment of the TB diagnostics market?

Partnerships with government agencies, international organizations, and local health authorities play a significant role in overcoming logistical barriers. Collaborations with NGOs and public-private partnerships help in reaching low-income regions, ensuring that TB diagnostic tools are both affordable and widely accessible. These partnerships also facilitate the implementation of large-scale TB eradication programs.

What role does training and support play in the midstream TB diagnostics market?

Training and support are crucial for the proper use of diagnostic tools. Healthcare providers need ongoing education to effectively use advanced diagnostic technologies like molecular tests and AI-based tools. Additionally, providing technical assistance ensures that diagnostic tools are used to their full potential, leading to accurate results and more effective TB management.

What is the role of end-users in the TB diagnostics market in 2025?

End-users in the TB diagnostics market primarily include healthcare professionals, such as doctors, laboratory technicians, and public health workers, who rely on accurate diagnostic tools for effective disease management. These end-users play a critical role in interpreting test results, diagnosing TB, and initiating timely treatment for patients.

What are the key activities in the downstream segment of the TB diagnostics market?

Key activities in the downstream segment involve the actual application of diagnostic tests, patient diagnosis, and treatment management. This includes interpreting test results, reporting findings, and monitoring treatment outcomes. Patient education and follow-up care are also essential to ensure adherence to TB treatment regimens and prevent disease transmission.

What are the challenges faced by downstream stakeholders in the TB diagnostics market?

Downstream stakeholders face challenges such as limited access to quality diagnostic tools in rural or low-resource settings, delays in reporting results, and inconsistent quality of care. Additionally, there is the ongoing issue of patient non-compliance with treatment protocols, particularly in areas with high stigma associated with TB.

How do healthcare policies impact the downstream segment of the TB diagnostics market?

Healthcare policies greatly influence the availability and accessibility of TB diagnostics. National health policies, funding allocation, and support for TB control programs affect the implementation of diagnostic technologies at the grassroots level. Effective policies can ensure that diagnostic tools are distributed widely and are affordable for all populations, particularly in high-burden regions.

What role does data management play in the downstream TB diagnostics market?

Data management is essential for tracking TB cases, monitoring patient progress, and ensuring proper treatment regimens are followed. Efficient data management systems help healthcare providers make informed decisions, improve diagnostic accuracy, and ensure continuity of care. Electronic health records and data-sharing platforms play a key role in streamlining these processes.

Chapter 1, to describe Tuberculosis (TB) Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Tuberculosis (TB) Diagnostics, with revenue, gross margin and global market share of Tuberculosis (TB) Diagnostics from 2018 to 2023.
Chapter 3, the Tuberculosis (TB) Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Tuberculosis (TB) Diagnostics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Tuberculosis (TB) Diagnostics.
Chapter 13, to describe Tuberculosis (TB) Diagnostics research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Tuberculosis (TB) Diagnostics
   1.2 Market Estimation Caveats and Base Year
   1.3 Classification of Tuberculosis (TB) Diagnostics by Type
       1.3.1 Overview: Global Tuberculosis (TB) Diagnostics Market Size by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type in 2022
       1.3.3 Culture-Based Diagnostics
       1.3.4 Sputum Smear Microscopy
       1.3.5 Rapid Molecular Diagnostics
       1.3.6 Others
   1.4 Global Tuberculosis (TB) Diagnostics Market by Application
       1.4.1 Overview: Global Tuberculosis (TB) Diagnostics Market Size by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Diagnostic Laboratories
       1.4.3 Hospitals
   1.5 Global Tuberculosis (TB) Diagnostics Market Size & Forecast
   1.6 Global Tuberculosis (TB) Diagnostics Market Size and Forecast by Region
       1.6.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
       1.6.2 Global Tuberculosis (TB) Diagnostics Market Size by Region, (2018-2029)
       1.6.3 North America Tuberculosis (TB) Diagnostics Market Size and Prospect (2018-2029)
       1.6.4 Europe Tuberculosis (TB) Diagnostics Market Size and Prospect (2018-2029)
       1.6.5 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size and Prospect (2018-2029)
       1.6.6 South America Tuberculosis (TB) Diagnostics Market Size and Prospect (2018-2029)
       1.6.7 Middle East and Africa Tuberculosis (TB) Diagnostics Market Size and Prospect (2018-2029)

2 Company Profiles

   2.1 Danaher
       2.1.1 Danaher Details
       2.1.2 Danaher Major Business
       2.1.3 Danaher Tuberculosis (TB) Diagnostics Product and Solutions
       2.1.4 Danaher Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Danaher Recent Developments and Future Plans
   2.2 Roche
       2.2.1 Roche Details
       2.2.2 Roche Major Business
       2.2.3 Roche Tuberculosis (TB) Diagnostics Product and Solutions
       2.2.4 Roche Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Roche Recent Developments and Future Plans
   2.3 Thermo Fisher Scientific
       2.3.1 Thermo Fisher Scientific Details
       2.3.2 Thermo Fisher Scientific Major Business
       2.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product and Solutions
       2.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
   2.4 BD
       2.4.1 BD Details
       2.4.2 BD Major Business
       2.4.3 BD Tuberculosis (TB) Diagnostics Product and Solutions
       2.4.4 BD Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 BD Recent Developments and Future Plans
   2.5 Abbott
       2.5.1 Abbott Details
       2.5.2 Abbott Major Business
       2.5.3 Abbott Tuberculosis (TB) Diagnostics Product and Solutions
       2.5.4 Abbott Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Abbott Recent Developments and Future Plans
   2.6 Hologic
       2.6.1 Hologic Details
       2.6.2 Hologic Major Business
       2.6.3 Hologic Tuberculosis (TB) Diagnostics Product and Solutions
       2.6.4 Hologic Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Hologic Recent Developments and Future Plans
   2.7 Qiagen
       2.7.1 Qiagen Details
       2.7.2 Qiagen Major Business
       2.7.3 Qiagen Tuberculosis (TB) Diagnostics Product and Solutions
       2.7.4 Qiagen Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Qiagen Recent Developments and Future Plans
   2.8 BioMerieux
       2.8.1 BioMerieux Details
       2.8.2 BioMerieux Major Business
       2.8.3 BioMerieux Tuberculosis (TB) Diagnostics Product and Solutions
       2.8.4 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 BioMerieux Recent Developments and Future Plans
   2.9 Hain Lifescience
       2.9.1 Hain Lifescience Details
       2.9.2 Hain Lifescience Major Business
       2.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Product and Solutions
       2.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Hain Lifescience Recent Developments and Future Plans
   2.10 Oxford Immunotec 
       2.10.1 Oxford Immunotec Details
       2.10.2 Oxford Immunotec Major Business
       2.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Product and Solutions
       2.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Oxford Immunotec Recent Developments and Future Plans

3 Market Competition, by Players

   3.1 Global Tuberculosis (TB) Diagnostics Revenue and Share by Players (2018-2023)
   3.2 Market Share Analysis (2022)
       3.2.1 Market Share of Tuberculosis (TB) Diagnostics by Company Revenue
       3.2.2 Top 3 Tuberculosis (TB) Diagnostics Players Market Share in 2022
       3.2.3 Top 6 Tuberculosis (TB) Diagnostics Players Market Share in 2022
   3.3 Tuberculosis (TB) Diagnostics Market: Overall Company Footprint Analysis
       3.3.1 Tuberculosis (TB) Diagnostics Market: Region Footprint
       3.3.2 Tuberculosis (TB) Diagnostics Market: Company Product Type Footprint
       3.3.3 Tuberculosis (TB) Diagnostics Market: Company Product Application Footprint
   3.4 New Market Entrants and Barriers to Market Entry
   3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

   4.1 Global Tuberculosis (TB) Diagnostics Consumption Value and Market Share by Type (2018-2023)
   4.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

   5.1 Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2018-2023)
   5.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Application (2024-2029)

6 North America

   6.1 North America Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2029)
   6.2 North America Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2029)
   6.3 North America Tuberculosis (TB) Diagnostics Market Size by Country
       6.3.1 North America Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2029)
       6.3.2 United States Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
       6.3.3 Canada Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
       6.3.4 Mexico Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)

7 Europe

   7.1 Europe Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2029)
   7.2 Europe Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2029)
   7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country
       7.3.1 Europe Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2029)
       7.3.2 Germany Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
       7.3.3 France Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
       7.3.4 United Kingdom Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
       7.3.5 Russia Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
       7.3.6 Italy Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)

8 Asia-Pacific

   8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2029)
   8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2029)
   8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region
       8.3.1 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Region (2018-2029)
       8.3.2 China Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
       8.3.3 Japan Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
       8.3.4 South Korea Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
       8.3.5 India Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
       8.3.6 Southeast Asia Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
       8.3.7 Australia Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)

9 South America

   9.1 South America Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2029)
   9.2 South America Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2029)
   9.3 South America Tuberculosis (TB) Diagnostics Market Size by Country
       9.3.1 South America Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2029)
       9.3.2 Brazil Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
       9.3.3 Argentina Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)

10 Middle East & Africa

   10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2029)
   10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2029)
   10.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country
       10.3.1 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2029)
       10.3.2 Turkey Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
       10.3.3 Saudi Arabia Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)
       10.3.4 UAE Tuberculosis (TB) Diagnostics Market Size and Forecast (2018-2029)

11 Market Dynamics

   11.1 Tuberculosis (TB) Diagnostics Market Drivers
   11.2 Tuberculosis (TB) Diagnostics Market Restraints
   11.3 Tuberculosis (TB) Diagnostics Trends Analysis
   11.4 Porters Five Forces Analysis
       11.4.1 Threat of New Entrants
       11.4.2 Bargaining Power of Suppliers
       11.4.3 Bargaining Power of Buyers
       11.4.4 Threat of Substitutes
       11.4.5 Competitive Rivalry
   11.5 Influence of COVID-19 and Russia-Ukraine War
       11.5.1 Influence of COVID-19
       11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

   12.1 Tuberculosis (TB) Diagnostics Industry Chain
   12.2 Tuberculosis (TB) Diagnostics Upstream Analysis
   12.3 Tuberculosis (TB) Diagnostics Midstream Analysis
   12.4 Tuberculosis (TB) Diagnostics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

   14.1 Methodology
   14.2 Research Process and Data Source
   14.3 Disclaimer

List of Tables

   Table 1. Global Tuberculosis (TB) Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Tuberculosis (TB) Diagnostics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Global Tuberculosis (TB) Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
   Table 4. Global Tuberculosis (TB) Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
   Table 5. Danaher Company Information, Head Office, and Major Competitors
   Table 6. Danaher Major Business
   Table 7. Danaher Tuberculosis (TB) Diagnostics Product and Solutions
   Table 8. Danaher Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 9. Danaher Recent Developments and Future Plans
   Table 10. Roche Company Information, Head Office, and Major Competitors
   Table 11. Roche Major Business
   Table 12. Roche Tuberculosis (TB) Diagnostics Product and Solutions
   Table 13. Roche Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 14. Roche Recent Developments and Future Plans
   Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
   Table 16. Thermo Fisher Scientific Major Business
   Table 17. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product and Solutions
   Table 18. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 19. Thermo Fisher Scientific Recent Developments and Future Plans
   Table 20. BD Company Information, Head Office, and Major Competitors
   Table 21. BD Major Business
   Table 22. BD Tuberculosis (TB) Diagnostics Product and Solutions
   Table 23. BD Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 24. BD Recent Developments and Future Plans
   Table 25. Abbott Company Information, Head Office, and Major Competitors
   Table 26. Abbott Major Business
   Table 27. Abbott Tuberculosis (TB) Diagnostics Product and Solutions
   Table 28. Abbott Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 29. Abbott Recent Developments and Future Plans
   Table 30. Hologic Company Information, Head Office, and Major Competitors
   Table 31. Hologic Major Business
   Table 32. Hologic Tuberculosis (TB) Diagnostics Product and Solutions
   Table 33. Hologic Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 34. Hologic Recent Developments and Future Plans
   Table 35. Qiagen Company Information, Head Office, and Major Competitors
   Table 36. Qiagen Major Business
   Table 37. Qiagen Tuberculosis (TB) Diagnostics Product and Solutions
   Table 38. Qiagen Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 39. Qiagen Recent Developments and Future Plans
   Table 40. BioMerieux Company Information, Head Office, and Major Competitors
   Table 41. BioMerieux Major Business
   Table 42. BioMerieux Tuberculosis (TB) Diagnostics Product and Solutions
   Table 43. BioMerieux Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 44. BioMerieux Recent Developments and Future Plans
   Table 45. Hain Lifescience Company Information, Head Office, and Major Competitors
   Table 46. Hain Lifescience Major Business
   Table 47. Hain Lifescience Tuberculosis (TB) Diagnostics Product and Solutions
   Table 48. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 49. Hain Lifescience Recent Developments and Future Plans
   Table 50. Oxford Immunotec Company Information, Head Office, and Major Competitors
   Table 51. Oxford Immunotec Major Business
   Table 52. Oxford Immunotec Tuberculosis (TB) Diagnostics Product and Solutions
   Table 53. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 54. Oxford Immunotec Recent Developments and Future Plans
   Table 55. Global Tuberculosis (TB) Diagnostics Revenue (USD Million) by Players (2018-2023)
   Table 56. Global Tuberculosis (TB) Diagnostics Revenue Share by Players (2018-2023)
   Table 57. Breakdown of Tuberculosis (TB) Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
   Table 58. Market Position of Players in Tuberculosis (TB) Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
   Table 59. Head Office of Key Tuberculosis (TB) Diagnostics Players
   Table 60. Tuberculosis (TB) Diagnostics Market: Company Product Type Footprint
   Table 61. Tuberculosis (TB) Diagnostics Market: Company Product Application Footprint
   Table 62. Tuberculosis (TB) Diagnostics New Market Entrants and Barriers to Market Entry
   Table 63. Tuberculosis (TB) Diagnostics Mergers, Acquisition, Agreements, and Collaborations
   Table 64. Global Tuberculosis (TB) Diagnostics Consumption Value (USD Million) by Type (2018-2023)
   Table 65. Global Tuberculosis (TB) Diagnostics Consumption Value Share by Type (2018-2023)
   Table 66. Global Tuberculosis (TB) Diagnostics Consumption Value Forecast by Type (2024-2029)
   Table 67. Global Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2023)
   Table 68. Global Tuberculosis (TB) Diagnostics Consumption Value Forecast by Application (2024-2029)
   Table 69. North America Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
   Table 70. North America Tuberculosis (TB) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
   Table 71. North America Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
   Table 72. North America Tuberculosis (TB) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
   Table 73. North America Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
   Table 74. North America Tuberculosis (TB) Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
   Table 75. Europe Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
   Table 76. Europe Tuberculosis (TB) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
   Table 77. Europe Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
   Table 78. Europe Tuberculosis (TB) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
   Table 79. Europe Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
   Table 80. Europe Tuberculosis (TB) Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
   Table 81. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
   Table 82. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
   Table 83. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
   Table 84. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
   Table 85. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
   Table 86. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
   Table 87. South America Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
   Table 88. South America Tuberculosis (TB) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
   Table 89. South America Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
   Table 90. South America Tuberculosis (TB) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
   Table 91. South America Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
   Table 92. South America Tuberculosis (TB) Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
   Table 93. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
   Table 94. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
   Table 95. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
   Table 96. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
   Table 97. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
   Table 98. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
   Table 99. Tuberculosis (TB) Diagnostics Raw Material
   Table 100. Key Suppliers of Tuberculosis (TB) Diagnostics Raw Materials

List of Figures

   Figure 1. Tuberculosis (TB) Diagnostics Picture
   Figure 2. Global Tuberculosis (TB) Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type in 2022
   Figure 4. Culture-Based Diagnostics
   Figure 5. Sputum Smear Microscopy
   Figure 6. Rapid Molecular Diagnostics
   Figure 7. Others
   Figure 8. Global Tuberculosis (TB) Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 9. Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application in 2022
   Figure 10. Diagnostic Laboratories Picture
   Figure 11. Hospitals Picture
   Figure 12. Global Tuberculosis (TB) Diagnostics Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 13. Global Tuberculosis (TB) Diagnostics Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 14. Global Market Tuberculosis (TB) Diagnostics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
   Figure 15. Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Region (2018-2029)
   Figure 16. Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Region in 2022
   Figure 17. North America Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 18. Europe Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 19. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 20. South America Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 21. Middle East and Africa Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 22. Global Tuberculosis (TB) Diagnostics Revenue Share by Players in 2022
   Figure 23. Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
   Figure 24. Global Top 3 Players Tuberculosis (TB) Diagnostics Market Share in 2022
   Figure 25. Global Top 6 Players Tuberculosis (TB) Diagnostics Market Share in 2022
   Figure 26. Global Tuberculosis (TB) Diagnostics Consumption Value Share by Type (2018-2023)
   Figure 27. Global Tuberculosis (TB) Diagnostics Market Share Forecast by Type (2024-2029)
   Figure 28. Global Tuberculosis (TB) Diagnostics Consumption Value Share by Application (2018-2023)
   Figure 29. Global Tuberculosis (TB) Diagnostics Market Share Forecast by Application (2024-2029)
   Figure 30. North America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2018-2029)
   Figure 31. North America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2018-2029)
   Figure 32. North America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2018-2029)
   Figure 33. United States Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 34. Canada Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 35. Mexico Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 36. Europe Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2018-2029)
   Figure 37. Europe Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2018-2029)
   Figure 38. Europe Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2018-2029)
   Figure 39. Germany Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 40. France Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 41. United Kingdom Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 42. Russia Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 43. Italy Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 44. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2018-2029)
   Figure 45. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2018-2029)
   Figure 46. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value Market Share by Region (2018-2029)
   Figure 47. China Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 48. Japan Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 49. South Korea Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 50. India Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 51. Southeast Asia Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 52. Australia Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 53. South America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2018-2029)
   Figure 54. South America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2018-2029)
   Figure 55. South America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2018-2029)
   Figure 56. Brazil Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 57. Argentina Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 58. Middle East and Africa Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2018-2029)
   Figure 59. Middle East and Africa Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2018-2029)
   Figure 60. Middle East and Africa Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2018-2029)
   Figure 61. Turkey Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 62. Saudi Arabia Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 63. UAE Tuberculosis (TB) Diagnostics Consumption Value (2018-2029) & (USD Million)
   Figure 64. Tuberculosis (TB) Diagnostics Market Drivers
   Figure 65. Tuberculosis (TB) Diagnostics Market Restraints
   Figure 66. Tuberculosis (TB) Diagnostics Market Trends
   Figure 67. Porters Five Forces Analysis
   Figure 68. Manufacturing Cost Structure Analysis of Tuberculosis (TB) Diagnostics in 2022
   Figure 69. Manufacturing Process Analysis of Tuberculosis (TB) Diagnostics
   Figure 70. Tuberculosis (TB) Diagnostics Industrial Chain
   Figure 71. Methodology
   Figure 72. Research Process and Data Source